01:50

China’s Sinovac Covid-19 vaccine proves more than 50 per cent effective in Brazil trials

Coronavirus pandemic

Sinovac Biotech’s CoronaVac vaccine above 50 per cent efficacy, says Brazilian institute

  • Sinovac Biotech’s vaccine meets the efficacy threshold set by Brazilian health regulator Anvisa
  • But Brazilian trial partner Butantan Institute says Sinovac had asked for a delay releasing precise efficacy data for up to 15 days

Topic |   Coronavirus pandemic

01:50

China’s Sinovac Covid-19 vaccine proves more than 50 per cent effective in Brazil trials

READ FULL ARTICLE